DCF Advisers, LLC
- SEC CIK
- 0001802493
- Latest filing
- Aug 10, 2026
CRVS holding history
Corvus Pharmaceuticals, Inc. in every 13F filed by DCF Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRVS overviewAll 13F holders of CRVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 637,500
- Value
- $9.52M
- % of portfolio
- 2.5%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 637,500 | $9.52M | 2.5% | 00.0% | Unchanged | Holders |
| Q1 2026 | 637,500 | $9.33M | 3.5% | −91,500−12.6% | Reduced | Holders |
| Q4 2025 | 729,000 | $5.61M | 1.9% | −39,500−5.1% | Reduced | Holders |
| Q3 2025 | 768,500 | $5.66M | 2.1% | +11,000+1.5% | Added | Holders |
| Q2 2025 | 757,500 | $3.03M | 1.5% | +357,500+89.4% | Added | Holders |
| Q1 2025 | 400,000 | $1.27M | 0.7% | +371,319+1,294.7% | Added | Holders |
| Q4 2024 | 28,681 | $153.4K | 0.1% | +28,681 | New | Holders |